XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period Of Adoption, Adjustment
Cumulative Effect, Period Of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period Of Adoption, Adjusted Balance
Paid-in Capital
Paid-in Capital
Cumulative Effect, Period Of Adoption, Adjusted Balance
Redeemable Perpetual Preferred Stock
Redeemable Perpetual Preferred Stock
Cumulative Effect, Period Of Adoption, Adjusted Balance
Distributions in Excess of Accumulated Earnings
Distributions in Excess of Accumulated Earnings
Cumulative Effect, Period Of Adoption, Adjustment
Distributions in Excess of Accumulated Earnings
Cumulative Effect, Period Of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period Of Adoption, Adjusted Balance
Non-controlling interests – Common OP Units
Non-controlling interests – Common OP Units
Cumulative Effect, Period Of Adoption, Adjusted Balance
Beginning balance at Dec. 31, 2019 $ 1,321,888 $ (3,875) $ 1,318,013 $ 1,812 $ 1,812 $ 1,402,696 $ 1,402,696 $ 0 $ 0 $ (154,318) $ (3,875) $ (158,193) $ (380) $ (380) $ 72,078 $ 72,078
Increase (Decrease) in Stockholders' Equity                                
Exchange of Common OP units for common stock (in shares)       0                        
Exchange of Common OP Units for Common Stock 0         63                 (63)  
Issuance of Common Stock through employee stock purchase plan 619         619                    
Compensation expenses related to restricted stock and stock options 2,964         2,964                    
Repurchase of Common Stock or Common OP Units (3,962)         (3,962)                    
Adjustment for Common OP Unitholders in the Operating Partnership 0         277                 (277)  
Adjustment for fair market value of swap (1,333)                       (1,333)      
Consolidated net income 70,724             0   66,875         3,849  
Distributions (65,975)             0   (62,385)         (3,590)  
Other (143)         (143)                    
Ending balance at Mar. 31, 2020 1,320,907     $ 1,812   1,402,514   0   (153,703)     (1,713)   71,997  
Beginning balance at Dec. 31, 2019 $ 1,321,888 $ (3,875) $ 1,318,013 1,812 $ 1,812 1,402,696 $ 1,402,696 0 $ 0 (154,318) $ (3,875) $ (158,193) (380) $ (380) 72,078 $ 72,078
Increase (Decrease) in Stockholders' Equity                                
Exchange of Common OP units for common stock (in shares) 9,228                              
Adjustment for fair market value of swap $ 380                              
Ending balance at Sep. 30, 2020 1,299,092     1,812   1,408,253   0   (181,754)     0   70,781  
Beginning balance at Mar. 31, 2020 1,320,907     1,812   1,402,514   0   (153,703)     (1,713)   71,997  
Increase (Decrease) in Stockholders' Equity                                
Issuance of Common Stock through employee stock purchase plan 531         531                    
Compensation expenses related to restricted stock and stock options 2,669         2,669                    
Adjustment for Common OP Unitholders in the Operating Partnership 0         193                 (193)  
Adjustment for fair market value of swap 552                       552      
Consolidated net income 48,853             8   46,187         2,658  
Distributions (65,986)             (8)   (62,387)         (3,591)  
Other (143)         (143)                    
Ending balance at Jun. 30, 2020 1,307,383     1,812   1,405,764   0   (169,903)     (1,161)   70,871  
Increase (Decrease) in Stockholders' Equity                                
Issuance of Common Stock through employee stock purchase plan 528         528                    
Compensation expenses related to restricted stock and stock options 2,878         2,878             0      
Adjustment for Common OP Unitholders in the Operating Partnership 0         (592)       0         592  
Adjustment for fair market value of swap 1,161                       1,161      
Consolidated net income 53,468                 50,560         2,908  
Distributions (66,001)                 (62,411)         (3,590)  
Other (325)         (325)                    
Ending balance at Sep. 30, 2020 1,299,092     1,812   1,408,253   0   (181,754)     0   70,781  
Beginning balance at Dec. 31, 2020 1,304,755     $ 1,813   1,411,397   0   (179,523)     0   71,068  
Increase (Decrease) in Stockholders' Equity                                
Exchange of Common OP units for common stock (in shares)       0                        
Exchange of Common OP Units for Common Stock 0         58                 (58)  
Issuance of Common Stock through employee stock purchase plan 732         732                    
Compensation expenses related to restricted stock and stock options 2,556         2,556                    
Repurchase of Common Stock or Common OP Units (2,814)         (2,814)                    
Adjustment for fair market value of swap 129                       129      
Consolidated net income 68,987             0   65,240         3,747  
Distributions (69,883)             0   (66,087)         (3,796)  
Other (116)         (116)                    
Ending balance at Mar. 31, 2021 1,304,346     $ 1,813   1,411,813   0   (180,370)     129   70,961  
Beginning balance at Dec. 31, 2020 $ 1,304,755     1,813   1,411,397   0   (179,523)     0   71,068  
Increase (Decrease) in Stockholders' Equity                                
Exchange of Common OP units for common stock (in shares) 1,451,710                              
Adjustment for fair market value of swap $ 325                              
Ending balance at Sep. 30, 2021 1,309,222     1,828   1,427,606   0   (181,941)     325   61,404  
Beginning balance at Mar. 31, 2021 1,304,346     $ 1,813   1,411,813   0   (180,370)     129   70,961  
Increase (Decrease) in Stockholders' Equity                                
Exchange of Common OP units for common stock (in shares)       14,000                        
Exchange of Common OP Units for Common Stock 0         9,310                 (9,324)  
Issuance of Common Stock through employee stock purchase plan 605         605                    
Compensation expenses related to restricted stock and stock options 2,821         2,821                    
Adjustment for Common OP Unitholders in the Operating Partnership 0         (143)                 143  
Adjustment for fair market value of swap 110                       110      
Consolidated net income 64,080             8   61,051         3,021  
Distributions (69,915)             (8)   (66,611)         (3,296)  
Other (56)         (56)                    
Ending balance at Jun. 30, 2021 1,301,991     $ 1,827   1,424,350   0   (185,930)     239   61,505  
Increase (Decrease) in Stockholders' Equity                                
Exchange of Common OP Units for Common Stock 0     1   438                 (439)  
Issuance of Common Stock through employee stock purchase plan 379         379                    
Compensation expenses related to restricted stock and stock options 2,774         2,774                    
Adjustment for Common OP Unitholders in the Operating Partnership 0         (142)                 142  
Adjustment for fair market value of swap 86                       86      
Consolidated net income 74,093     0       0   70,625     0   3,468  
Distributions (69,908)             0   (66,636)         (3,272)  
Other (193)         (193)                    
Ending balance at Sep. 30, 2021 $ 1,309,222     $ 1,828   $ 1,427,606   $ 0   $ (181,941)     $ 325   $ 61,404